Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Ther Drug Monit. 2021 Dec 1;43(6):780–788. doi: 10.1097/FTD.0000000000000885

Table 2:

Pharmacokinetic parameters of bupropion (BUP) and its metabolites as determined in the second and third trimester of pregnancy when compared with 6–12 weeks postpartum in the same subjects

Parameter T2 vs Matched Postpartum (n=5) T3 vs Matched Postpartum (n=5)
T2 PP P-Value T3 PP P-Value
BUP Css (μM/g) 0.33 [0.08–1.2] 0.53 [0.11–1.3] 0.4787 0.44 [0.19–1.2] 0.41 [0.11–1.1] 0.8056
CLR (L/h) 2.4 [0.77–6.4] 1.1 [0.09–18.5] 0.4548 1.8 [0.26–11.8] 1.9 [0.26–18.5] 0.97
OH-BUP Css OH-BUP (μM/g) 15.1 [10.6–18.7] 16.3 [4.9–39.6] 0.7839 16.5 [6.3–30.9] 13.3 [4.9–39.6] 0.6896
CLR (L/h) 0.20 [0.11–0.36] 0.10 [0.02–0.54] 0.2937 0.08 [0.04–0.12] 0.10 [0.03–0.46] 0.5539
CLf (L/h) 50.7 [9.9–400.9] 13.4 [1.7–120.8] 0.1619 24.9 [5.8–71.2] 15.9 [3.1–120.8] 0.228
S,S-OH-BUP Css (μM/g) 0.73 [0.20–1.4] 0.78 [0.10–2.2] 0.7772 0.83 [0.36–1.7] 0.64 [0.10–2.2] 0.4699
CLR (L/h) 0.93 [0.31–3.4] 0.35 [0.09–3.5] 0.1707 0.40 [0.24–0.72] 0.47 [0.09–3.5] 0.7751
SS-OH-BUP/ BUP 2.2 [1.0–6.0] 1.5 [0.7–5.9] 0.4729 1.9 [0.9–8.7] 1.6 [0.8–5.9] 0.4943
R,R-OH-BUP Css (μM/g) 15.8 [10.0–22.2] 15.9 [5.5–35.7] 0.9786 13.7 [5.9–21.2] 14.0 [5.5–35.7] 0.9647
CLR (L/h) 0.15 [0.07–0.32] 0.08 [0.02–0.45] 0.3564 0.07 [0.05–0.09] 0.09 [0.03–0.35] 0.6659
RR-OH-BUP/ BUP 43.8 [16.4–178.7] 32.5 [15.8–77.2] 0.5907 33.7 [13.5–99.1] 35.6 [15.2–77.2] 0.8544
Threo Css (μM/g) 3.4 [1.8–6.7] 4.1 [1.2–10.8] 0.4896 4.9 [3.1–10.7] 4.7 [1.2–10.8] 0.8675
CLR (L/h) 3.9 [1.7–8.6] 2.4 [0.55–17.6] 0.381 2.0 [1.1–2.8] 2.9 [0.59–17.6] 0.5748
CLf (L/h) 89.4 [20.1–275.8] 34.5 [2.9–166.4] 0.2477 56.6 [17.0–208.0] 68.5 [15.8–166.4] 0.5949
Threo/ BUP 10.3 [4.8–23.1] 7.8 [3.5–17.6] 0.545 11.2 [5.6–16.6] 11.5 [9.7–17.6] 0.8878
Erythro Css (μM/g) 0.49 [0.33–0.78] 0.67 [0.25–1.7] 0.2739 0.63 [0.52–0.79] 0.80 [0.25–1.7] 0.4832
CLR (L/h) 2.1 [0.91–4.4] 1.6 [0.36–9.7] 0.5107 1.2 [0.74–1.7] 1.9 [0.36–9.7] 0.4811
CLf (L/h) 23.8 [3.9–105.8] 10.6 [1.3–70.7] 0.3067 17.9 [4.1–112.1] 21.1 [4.9–70.7] 0.5992
Erythro/ BUP 1.5 [0.4–4.2] 1.3 [0.5–3.2] 0.771 1.4 [0.6–2.7] 1.9 [1.2–3.2] 0.1358
Threo-OH CLf (L/h) 2.4 [0.4–12.4] 1.2 [0.4–4.9] 0.0809 1.7 [0.2–8.9] 1.7 [0.4–4.9] 0.9983
Erythro-OH CLf (L/h) 10.8 [3.2–39.8] 5.1 [1.7–20.8] 0.025 9.4 [2.5–36.7] 7.6 [2.6–20.8] 0.556
4’OH-BUP CLf (L/h) 1.5 [0.1–28.2] 0.7 [0.0–5.7] 0.6186 0.8 [0.1–4.8] 1.0 [0.3–5.7] 0.3921

OH-BUP, hydroxybupropion; Threo, threohydrobupropion; Erythro, erythrohydrobupropion; 4’OH-BUP, 4’-hydroxy-bupropion; T2, second trimester; T3, third trimester; PP, postpartum (defined as 6–12 weeks after delivery)

Values shown above include the geometric mean and [range]. Data were log-transformed for analysis with paired t-test

Steady-state concentrations (Css) are presented as dose-normalized.